|
|
![]() | ![]() | ![]() | ![]() |
| |||||||||
This excerpt taken from the ELN 20-F filed Feb 26, 2009. Equity
securities current
At December 31, 2008, marketable equity securities
primarily consisted of investments in emerging pharmaceutical
and biotechnology companies. The fair market value of these
securities was $2.7 million at December 31, 2008
(2007: $8.8 million).
This excerpt taken from the ELN 20-F filed Feb 28, 2008. Equity
securities current
At December 31, 2007, marketable equity securities
primarily consisted of investments in emerging pharmaceutical
and biotechnology companies. The fair market value of these
securities was $8.8 million at December 31, 2007
(2006: $11.2 million).
| EXCERPTS ON THIS PAGE:
RELATED TOPICS for ELN: |
| |||||||